ReSEARCH BAM


REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
Projektleitung
	Dr. rer. nat. Knut Rurack BAM - 1.9 Chemische und optische Sensorik E-Mail: Knut.Rurack@bam.de ORCID: https://orcid.org/0000-0002-5589-5548 Researcher-ID: B-1079-2009
Förderstruktur
	EU - Europäische Kommission - H2020 - Societal Challenge 1: Better Health and care, economic growth and sustainable health systems
Projektbeginn
	01.01.2020
Projektende
	31.12.2024
Projektart
	Realisierte Antragsforschung
Themen-/Aktivitätsfeld
	THEMENFELD Analytical Sciences, * Sensorik
Abstract
	The EU-funded REVERT project will address at systems level the pathophysiology of advanced colorectal cancer in patients responding well or poorly to therapies, with the goal to design an optimal strategy for therapeutic interventions depending on patients' features. This goal will be achieved using a large number of standardised biobank samples and clinical databases from several clinical European centres, including known and new potential prognostic biomarkers. Following the AI-based data analysis, results will be evaluated for the REVERT-DataBase impact on survival and quality of life in prospective clinical trials. The project will also generate a broad network among industrial and academic partners focused on the development of personalised medicine.